Loading clinical trials...
Loading clinical trials...
This study is designed to treat systemic sclerosis (scleroderma) patients with an autologous stem cell transplant using a regimen of immune suppressant drugs and chemotherapy that is less toxic to you...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Northwestern University
NCT07526350 · Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathies, and more
NCT06329401 · Pulmonary Fibrosis, Progressive Pulmonary Fibrosis, and more
NCT03844061 · Systemic Sclerosis
NCT07491523 · SSc-Systemic Sclerosis
NCT07470151 · System Lupus Erythematosus(SLE), Scleroderma, and more
Northwestern University, Feinberg School of Medicine
Chicago, Illinois
Northwestern University
Chicago, Illinois
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions